Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Tabali, Manuela ^a   Jeschke, Elke ^a   Bockelbrink, Angelina ^b   Witt, Claudia M ^b   Willich, Stefan N ^b   Ostermann, Thomas ^c   Matthes, Harald ^a  

^a Havelhoehe Research Institute   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; HOMEOPATHIC AGENT; DRUG;

ADULT; ADVERSE DRUG REACTION; ALTERNATIVE MEDICINE; ARTICLE; AWARENESS; CALCULATION; CHI SQUARE TEST; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; EVALUATION; FEMALE; HUMAN; INTERRATER RELIABILITY; INTERVENTION STUDY; KNOWLEDGE; MALE; MEDICAL EDUCATION; MONITORING; MULTICENTER STUDY; PHYSICIAN; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RANK SUM TEST; TRAINING; UNSPECIFIED SIDE EFFECT; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE;

COMPLEMENTARY THERAPIES; EDUCATION, MEDICAL, CONTINUING; HUMANS; PHARMACEUTICAL PREPARATIONS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES;

EID: 69149097902     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-274     Document Type: Article

References (30)

1. Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre. WHO, http://www.who.int/medicinedocs Accessed May 16, 2005
2. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J Lazarou BH Pomeranz PN Corey, JAMA 1998 279 1200 1205 10.1001/jama.279.15.1200 9555760
3. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. C Kongkaew PR Noyce DM Ashcroft, Ann Pharmacother 2008 42 1017 1025 10.1345/aph.1L037 18594048
4. Safety of Medicines: A guide to detecting and reporting adverse drug reactions. Why health professionals need to take action? WHO, http://apps.who.int/medicinedocs
5. EU: Berliner Deklaration zur Pharmakovigilanz Wie sich die Sicherheit von Arzneimitteln verbessern lässt. ISDB, http://www.isdbweb.org Accessed May 16, 2005
6. Determinants of under-reporting of adverse drug reactions: a systematic review. E Lopez-Gonzalez MT Herdeiro A Figueiras, Drug Saf 2009 32 19 31 10.2165/00002018-200932010-00002 19132802
7. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. MT Herdeiro A Figueiras J Polonia JJ Gestal-Otero, Drug Saf 2005 28 825 833 10.2165/00002018-200528090-00007 16119975
8. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. A Figueiras MT Herdeiro J Polonia JJ Gestal-Otero, JAMA 2006 296 1086 1093 10.1001/jama.296.9.1086 16954488
9. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme. RC Bracchi J Houghton FJ Woods S Thomas SA Smail PA Routledge, Br J Clin Pharmacol 2005 60 221 223 10.1111/j.1365-2125. 2005.02419.x 16042677
10. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. M Cosentino O Leoni F Banfi S Lecchini G Frigo, Pharmacol Res 1997 35 85 88 10.1006/phrs.1996.0138 9175573
11. Changing provider behavior: an overview of systematic reviews of interventions. JM Grimshaw L Shirran R Thomas G Mowatt C Fraser L Bero R Grilli E Harvey A Oxman MA O'Brien, Med Care 2001 39 II2 45 10.1097/00005650-200108002- 00002 11583120
12. [Use and acceptance of classical natural and alternative medicine in Germany - findings of a representative population-based survey]. U Hartel E Volger, Forsch Komplementarmed Klass Naturheilkd 2004 11 327 334 10.1159/000082814 15604623
13. Trends in use of complementary and alternative medicine by US adults: 1997-2002. HA Tindle RB Davis RS Phillips DM Eisenberg, Altern Ther Health Med 2005 11 42 49 15712765
14. The other side of the coin: safety of complementary and alternative medicine. SP Myers PA Cheras, Med J Aust 2004 181 222 225 15310261
15. Survey of the use of complementary medicines and therapies in children with asthma. G Shenfield E Lim H Allen, J Paediatr Child Health 2002 38 252 257 10.1046/j.1440-1754.2002.00770.x 12047692
16. Physicians should increase knowledge of herbal remedies. D Levenson, Rep Med Guidel Outcomes Res 2001 12 7 9
17. How objective are systematic reviews? Differences between reviews on complementary medicine. K Linde SN Willich, J R Soc Med 2003 96 17 22 10.1258/jrsm.96.1.17 12519797
18. Monitoring herbal safety: Current debate and resources Symposium report: Pharmacovigilance of herbal medicines: Curent state and future direction. S Mills, London, 24-26 April 2006. Phystomedicine 2006
19. Ein Pharmakovigilanzsystem für Arzneimittel der besonderen Therapierichtungen. H Matthes M Tabali E Jeschke, EHK 2008 57 34 10.1055/s-2008-1044005
20. QuaDoSta - ein frei konfigurierbares System zur Unterstützung multizentrischer Datenerhebungen in medizinischer Versorgung und Forschung. E Jeschke F Schad J Pissarek B Matthes U Albrecht H Matthes, GMS Medizinische Informatik, Biometrie und Epidemiologie 2007 3 10
21. [Prescribing practices in the treatment of upper respiratory tract infections in anthroposophic medicine]. E Jeschke C Luke T Ostermann M Tabali J Hubner H Matthes, Forsch Komplement Med (2006) 2007 14 207 215 10.1159/000104171
22. E2A: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. ICH, http://www.ich.org Accessed January 15, 2003
23. Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre. UMC, http://www.who.int/medicinedocs Accessed January 15, 2003
24. Attitudinal survey of voluntary reporting of adverse drug reactions. IA Eland KJ Belton AC van Grootheest AP Meiners MD Rawlins BH Stricker, Br J Clin Pharmacol 1999 48 623 627 10.1046/j.1365-2125.1999.00060.x 10583035
25. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Hasford M Goettler KH Munter B Muller-Oerlinghausen, J Clin Epidemiol 2002 55 945 950 10.1016/S0895-4356(02) 00450-X 12393084
26. Pharmacovigilance of herbal medicines: a UK perspective. J Barnes, Drug Saf 2003 26 829 851 10.2165/00002018-200326120-00001 12959628
27. Spontaneous reporting of adverse drug reactions by nurses. M Backstrom T Mjorndal R Dahlqvist, Pharmacoepidemiol Drug Saf 2002 11 647 650 10.1002/pds.753 12512239
28. Contribution of pharmacists to the reporting of adverse drug reactions. AC van Grootheest EP van Puijenbroek LT de Jong-van den Berg, Pharmacoepidemiol Drug Saf 2002 11 205 210 10.1002/pds.702 12051119
29. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. MT Herdeiro A Figueiras J Polonia JJ Gestal-Otero, Drug Saf 2006 29 331 340 10.2165/00002018-200629040-00004 16569082
30. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. MT Herdeiro J Polonia JJ Gestal-Otero A Figueiras, Drug Saf 2008 31 335 344 10.2165/00002018-200831040-00007 18366244